Ispire Technology (ISPR) investor relations material

Executive summary

• Q2 2026 revenue was $20.3 million, down from $41.8 million year-over-year, reflecting a strategic pivot to high-value nicotine sector clients and away from cannabis and slower-paying customers, with net loss improving to $6.6 million from $8.0 million.

• Gross margin declined to 17.1% from 18.5% year-over-year due to product mix changes.

• Operating expenses fell to $10.3 million from $15.1 million, reflecting disciplined cost controls and reductions in payroll, marketing, and professional fees.

• Net accounts receivable improved to $37.9 million from $47 million at fiscal year-end 2025, supporting improved cash flow.

• Significant progress was made on innovation projects, including IKE Tech age-gating, G-Mesh technology, and Malaysian manufacturing expansion.

Financial highlights

• Q2 2026 revenue was $20.3 million, down from $41.8 million in Q2 2025; six-month revenue was $50.6 million, down from $81.2 million.

• Gross profit was $3.5 million, with gross margin at 17.1%.

• Operating expenses for the quarter were $10.3 million, down from $15.1 million year-over-year.

• Net loss for the quarter was $6.6 million ($0.12 per share), compared to $8.0 million ($0.14 per share) year-over-year.

• Cash balance at December 31, 2025, was $17.6 million; working capital stood at $3.5 million.

Outlook and guidance

• Management expects continued improvement in cost structure, accounts receivable, and a return to revenue growth and profitability through fiscal 2026.

• Anticipates a pickup in revenue as new deals and innovations come online, especially with age-gating technology and Malaysian facility ramp-up.

• Current cash and cash flows from operations, along with recent equity offerings and borrowings, are expected to be sufficient for working capital needs over the next 12 months.

• Additional financing may be required if adverse conditions arise or if growth accelerates.